Timestamps
Minute 1:00 - How Fei ended up VC as a doctor
Minute 3:20 - Why did Fei go into VC
Minute 5:20 - Learnings from a VC about business models that work
Minute 6:50 - Importance of product market fit and what to keep in mind
Minute 12:00 - Re-engineering the startup process
Minute 14:00 - Patterns of healthcare and biotech innovation
Minute 17:00 - What VCs talk about with each other and the importance of a network in healthcare
Minute 21:00 - What are the most interesting applications and cases in health and biotech right now?
Minute 25:00 - Collaboration between tech and health experts
Minute 28:30 - How to bring your science and research to market
Minute 32:50 - What is valuation and how VCs approach valuation of startups - Fei’s valuation template
Minute 41:20 - Fei’s advice for fundraising strategies - how to fundraise
Minute 49:30 - Red Flags for VCs - What to avoid as founder
Minute 55:00 - Current market situation
Minute 58:10 - What is your wish for our healthcare future
Description
In this episode of our episode of Healthcare Minutes, I had the opportunity to speak with Dr. Fei Tian, a seasoned VC professional in life sciences and healthcare. Fei brings a wealth of experience as trained medical doctor, from her time as a VC Principal at Vesalius Biocapital, focusing on biotech, medtech, diagnostics, and digital health across Europe, her role as VC at Yabeo to her analytical roles in healthcare consulting with Novumed Life Science Consulting & Advisory Advisor at RoxHealth and now as a VC for MIG capital.
We delved into why Fei transitioned from clinical practice in emergency medicine to venture capital, highlighting due to her drive to enable disruptive innovations that promise significant impacts on the future of medicine and healthcare. We discussed the investment landscape of life sciences, discussing strategies for entrepreneurs to validate market needs, attract investment, and understand the critical factors that influence startup valuations from a VC perspective.
Here are some questions we addressed:
▶ Fei’s Career Choice:
Chose venture capital over clinical practice; factors to consider.
▶ Business Models:
Tech push versus market-based approaches for life science and healthcare ventures.
▶ Market Validation:
Strategies for founders to validate the right market.
▶ Investment Patterns:
Discussed investment matrices in life science and healthcare.
▶ Network Importance in healthcare:
The critical role of building a strong network to succeed.
▶ Investor Traction:
What is necessary to attract life science and healthcare investors.
▶ Valuation Approach:
How to handle startup valuation from a VC perspective. Do’s and Don`ts
▶ Finding the Right VC:
Tips for selecting the appropriate venture capital for your venture.
▶ VC Red-Flags:
Highlighted potential red flags for VCs and strategies to avoid them.
▶ Market Dynamics:
Current VC market conditions, including dry powder availability and investment openness.
Fei’s advice to emerging healthcare ventures is to balance technology-driven solutions with market demands, emphasizing the importance of building a robust network and choosing the right venture capital partner that aligns with the startup’s vision and goals.
Share this post